China Money Network
Login
Join

Chinese Biopharma Firm CANbridge Life Sciences Raises $25M In Series B Round

  • May 24, 2017 — 13:19 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese biopharmaceutical company CANbridge Life Sciences has raised US$25 million in a series B round from lead investor Lapam Capital, a Beijing-based life science venture... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: